ALC
Alcon Inc. - Registered Shares

553
Mkt Cap
$39.63B
Volume
1.4M
52W High
$99.20
52W Low
$71.55
PE Ratio
37.85
ALC Fundamentals
Price
$80.13
Prev Close
$80.62
Open
$80.35
50D MA
$78.09
Beta
0.77
Avg. Volume
1.25M
EPS (Annual)
$2.06
P/B
1.78
Rev/Employee
$387,163.56
Loading...
Loading...
News
all
press releases
Alcon Terminates Merger Agreement With STAAR Surgical
(RTTNews) - Alcon (ALC) announced Tuesday that it terminated its definitive merger agreement with STAAR Surgical Company (STAA) announced on August 5, 2025...
Nasdaq News: Markets·5d ago
News Placeholder
More News
News Placeholder
Alcon Terminates Agreement to Acquire STAAR Surgical
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today terminated its definitive merger agreement with STAAR Surgical Company (NASDAQ: STAA) announced...
Business Wire·5d ago
News Placeholder
STAAR Surgical Merger With Alcon Fails After Shareholders Vote No
STAAR Surgical said shareholders rejected its merger with Alcon, ending the $1.6 billion deal. The eye care company will remain independent and focus on growth and wider use of its EVO lens.read more...
Benzinga·5d ago
News Placeholder
Broadwood Partners Comments on STAAR Surgical Shareholders Rejection of the Companys Proposed Sale to Alcon
Broadwood Partners, L.P. and its affiliates (Broadwood or we), which together own 30.2% of the outstanding common stock of STAAR Surgical Company (STAAR or the Company) (NASDAQ: STAA), commented on...
Business Wire·5d ago
News Placeholder
Alcon to Present at 2026 Annual J.P. Morgan Healthcare Conference
Alcon (SIX/NYSE: ALC) CEO David Endicott will present at the 2026 J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 a.m. PST. A live webcast of the conference will be available...
Business Wire·12d ago
News Placeholder
Broadwood Partners Denounces STAAR Surgicals Fourth Delay of the Shareholder Vote on the Companys Proposed Sale to Alcon
Broadwood Partners, L.P. and its affiliates (Broadwood or we), which together own 30.2% of the outstanding common stock of STAAR Surgical Company (STAAR or the Company) (NASDAQ: STAA), today...
Business Wire·23d ago
News Placeholder
Alcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders
STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the Implantable Collamer Lens (ICL) today announced that Alcon (SIX/NYSE: ALC) has exercised its right under the Alcon merger agreement to...
Business Wire·23d ago
News Placeholder
Defender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc.
Defender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc. Defender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc...
PR Newswire·25d ago
News Placeholder
Broadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails
Broadwood Partners, L.P. and its affiliates (collectively, Broadwood) today issued the following letter to the Board of Directors (the Board) of STAAR Surgical Company (STAAR or the Company) (NASDAQ...
Business Wire·25d ago
News Placeholder
STAAR Stockholders Have a Choice: Vote FOR Alcons Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer Lenses (EVO ICL) for vision correction, today issued the following open letter to...
Business Wire·25d ago
<
1
2
...
>

Latest ALC News

View

Advertisement|Remove ads.

Advertisement|Remove ads.